600223 福瑞达
已收盘 09-04 15:00:00
资讯
新帖
简况
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告》
证券之星 · 09-03 02:24
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告》
福瑞达（600223）披露控股股东协议转让部分公司股份过户完成公告，9月1日股价上涨1.95%
证券之星 · 09-01
福瑞达（600223）披露控股股东协议转让部分公司股份过户完成公告，9月1日股价上涨1.95%
【东吴商社】福瑞达2026年半年报点评：Q2利润降幅明显收窄，化妆品板块表现亮眼
草叔消费升级研究 · 08-28
【东吴商社】福瑞达2026年半年报点评：Q2利润降幅明显收窄，化妆品板块表现亮眼
研报掘金丨东吴证券：维持福瑞达“买入”评级，化妆品板块表现亮眼
格隆汇 · 08-27
研报掘金丨东吴证券：维持福瑞达“买入”评级，化妆品板块表现亮眼
福瑞达（600223）2026年中报简析：增收不增利，公司应收账款体量较大
证券之星 · 08-27
福瑞达（600223）2026年中报简析：增收不增利，公司应收账款体量较大
福瑞达(600223.SH)发布半年度业绩，归母净利润8178万元，同比下降24.25%
智通财经 · 08-25
福瑞达(600223.SH)发布半年度业绩，归母净利润8178万元，同比下降24.25%
福瑞达（600223）披露2026年半年度报告，8月25日股价上涨4.14%
证券之星 · 08-25
福瑞达（600223）披露2026年半年度报告，8月25日股价上涨4.14%
福瑞达：企业留存收益是支撑业务拓展、研发投入、产能建设的核心
证券之星 · 08-25
福瑞达：企业留存收益是支撑业务拓展、研发投入、产能建设的核心
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司第十二届董事会独立董事专门会议决议》
证券之星 · 08-17
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司第十二届董事会独立董事专门会议决议》
每周股票复盘：福瑞达（600223）控股股东拟转让5%股份
证券之星 · 08-16
每周股票复盘：福瑞达（600223）控股股东拟转让5%股份
福瑞达（600223）披露与山东省商业集团财务有限公司签订《金融服务协议》暨关联交易公告，8月14日股价下跌0.35%
证券之星 · 08-14
福瑞达（600223）披露与山东省商业集团财务有限公司签订《金融服务协议》暨关联交易公告，8月14日股价下跌0.35%
股市必读：福瑞达（600223）8月13日董秘有最新回复
证券之星 · 08-14
股市必读：福瑞达（600223）8月13日董秘有最新回复
福瑞达：近三年累计分红超2.7亿元
证券之星 · 08-10
福瑞达：近三年累计分红超2.7亿元
福瑞达：通过股权合作推进业务合作
证券之星 · 08-07
福瑞达：通过股权合作推进业务合作
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司简式权益变动报告书（山东省国有资产投资控股有限公司）》
证券之星 · 08-07
股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司简式权益变动报告书（山东省国有资产投资控股有限公司）》
福瑞达(600223.SH)控股股东拟向山东国投转让5%公司股份
智通财经 · 08-06
福瑞达(600223.SH)控股股东拟向山东国投转让5%公司股份
福瑞达：近三年累计分红超2.7亿元
证券之星 · 08-06
福瑞达：近三年累计分红超2.7亿元
福瑞达：国资股东对管理层实行综合绩效考核体系
证券之星 · 07-28
福瑞达：国资股东对管理层实行综合绩效考核体系
福瑞达：以夯实主业基本面为核心开展市值管理
证券之星 · 07-28
福瑞达：以夯实主业基本面为核心开展市值管理
每周股票复盘：福瑞达（600223）聚焦医美器械与重组胶原蛋白布局
证券之星 · 07-26
每周股票复盘：福瑞达（600223）聚焦医美器械与重组胶原蛋白布局
加载更多
公司概况
公司名称：
鲁商福瑞达医药股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2000-01-13
主营业务：
鲁商福瑞达医药股份有限公司的主营业务是化妆品、医药、原料及添加剂的研发、生产与销售以及物业服务业务。公司的主要产品是化妆品、药品、原料及衍生产品、添加剂、物业服务。
发行价格：
6.80
{"stockData":{"symbol":"600223","market":"SH","secType":"STK","nameCN":"福瑞达","latestPrice":5.68,"timestamp":1788505200000,"preClose":5.6,"halted":0,"volume":9269283,"delay":0,"changeRate":0.0143,"floatShares":1017000000,"shares":1017000000,"eps":0.159,"marketStatus":"已收盘","change":0.08,"latestTime":"09-04 15:00:00","open":5.6,"high":5.73,"low":5.56,"amount":52629800,"amplitude":0.0304,"askPrice":5.68,"askSize":65,"bidPrice":5.67,"bidSize":192,"shortable":0,"etf":0,"ttmEps":0.159,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":5.6,"symbolType":"stock","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":6.16,"lowLimit":5.04,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1016568775,"isCdr":false,"pbRate":1.36,"roa":"--","peRate":35.72327,"roe":"1.91%","epsLYR":0.18,"committee":-0.233649,"marketValue":5774000000,"turnoverRate":0.0091,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-07。","floatMarketCap":5774000000},"requestUrl":"/m/hq/s/600223","defaultTab":"news","newsList":[{"id":"2664984574","title":"股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664984574","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664984574?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:24","pubTimestamp":1788373453,"startTime":"0","endTime":"0","summary":"公司公告汇总鲁商福瑞达医药股份有限公司关于控股股东协议转让部分公司股份过户完成的公告鲁商福瑞达医药股份有限公司控股股东山东省商业集团有限公司与山东省国有资产投资控股有限公司于2026年8月6日签署《股份转让协议》，拟转让公司50,828,500股股份，转让价格为5.384元/股，转让对价273,660,644.00元。转让后，山东省商业集团有限公司持股比例由51.62%降至46.62%，山东国投持股比例为5.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0273","159938","09939","600223","BK0188","BK1515","BK1161","BK0229","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664850386","title":"福瑞达（600223）披露控股股东协议转让部分公司股份过户完成公告，9月1日股价上涨1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664850386","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664850386?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:08","pubTimestamp":1788275297,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，福瑞达报收于5.75元，较前一交易日上涨1.95%，最新总市值为58.45亿元。近日，鲁商福瑞达医药股份有限公司发布《关于控股股东协议转让部分公司股份过户完成的公告》。转让后，山东省商业集团有限公司持股比例由51.62%降至46.62%，山东国投持股比例为5.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0229","BK0273","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091455","title":"【东吴商社】福瑞达2026年半年报点评：Q2利润降幅明显收窄，化妆品板块表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091455","media":"草叔消费升级研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662091455?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:07","pubTimestamp":1787904420,"startTime":"0","endTime":"0","summary":"投资要点公司公布2026年上半年业绩。化妆品板块表现亮眼，收入毛利率双升，新品牌及新品持续放量。化妆品板块实现收入12.9亿元，同比+18%；毛利率68.2%，同比+6pct。新品方面，颐莲胶原蛋白喷雾、水光精华面膜，瑷尔博士王浆酸系列及珂谧穿膜次抛等新品快速放量，推动化妆品板块收入及毛利率提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzIwMjU2Nzg0MQ==&mid=2247558067&idx=4&sn=0bea74677be09ff80ecb14671c36010d&chksm=977ac3640b3b3e2ca0dfb10ff0107dc6e5d37292e8642f45ad289423004f7b69ebed68249a4e&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["600223","BK0273","BK0229","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779438","title":"研报掘金丨东吴证券：维持福瑞达“买入”评级，化妆品板块表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779438","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662779438?lang=zh_cn&edition=full","pubTime":"2026-08-27 15:53","pubTimestamp":1787817192,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600223","BK0229","601555","BK0276","BK0012","BK0009","BK0183","BK0273","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740304","title":"福瑞达（600223）2026年中报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740304?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:03","pubTimestamp":1787781798,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期福瑞达发布2026年中报。截至本报告期末，公司营业总收入19.09亿元，同比上升6.69%，归母净利润8178.15万元，同比下降24.25%。本报告期福瑞达公司应收账款体量较大，当期应收账款占最新年报归母净利润比达266.14%。本次财报公布的各项数据指标表现一般。去年的净利率为6.5%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0229","BK0273","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662755117","title":"福瑞达(600223.SH)发布半年度业绩，归母净利润8178万元，同比下降24.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662755117","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662755117?lang=zh_cn&edition=full","pubTime":"2026-08-25 23:35","pubTimestamp":1787672134,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福瑞达 披露2026年半年度报告，报告期公司实现营业收入19.09亿元，同比增长6.69%;归属于上市公司股东的净利润8178万元，同比下降24.25%;归属于上市公司股东的扣除非经常性损益的净利润7659万元，同比下降26.77%;基本每股收益0.08元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600223"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758721","title":"福瑞达（600223）披露2026年半年度报告，8月25日股价上涨4.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758721","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758721?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:21","pubTimestamp":1787667666,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，福瑞达报收于5.78元，较前一交易日上涨4.14%，最新总市值为58.76亿元。该股当日开盘5.64元，最高5.97元，最低5.59元，成交额达1.31亿元，换手率为2.24%。近日，鲁商福瑞达医药股份有限公司披露《2026年半年度报告》。公告显示，公司总资产为5,936,421,257.20元，较上年度末增长1.34%；归属于上市公司股东的净资产为4,256,657,172.35元，较上年度末增长0.56%。经营活动产生的现金流量净额为34,432,534.76元，同比增长84.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600223","BK0229","BK0273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662073861","title":"福瑞达：企业留存收益是支撑业务拓展、研发投入、产能建设的核心","url":"https://stock-news.laohu8.com/highlight/detail?id=2662073861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662073861?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:42","pubTimestamp":1787650927,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞达08月25日在投资者关系平台上答复投资者关心的问题。不管从什么角度来分析，贵司股利都太低了，建议增加股息支付率，或者将2.3元/股的留存收益分配给投资者。企业留存收益是支撑业务拓展、研发投入、产能建设的核心，若将全部留存利润进行分配，将压缩公司战略投入空间，影响中长期成长潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0188","BK0229","BK0273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170056","title":"股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司第十二届董事会独立董事专门会议决议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660170056?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:57","pubTimestamp":1786906628,"startTime":"0","endTime":"0","summary":"公司公告汇总鲁商福瑞达医药股份有限公司第十二届董事会独立董事专门会议决议鲁商福瑞达医药股份有限公司第十二届董事会独立董事专门会议于2026年8月13日以通讯方式召开，应参会独立董事2名，实际参加表决2名，会议合法有效。同意将该议案提交公司第十二届董事会2026年第二次临时会议审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0273","BK1574","BK0188","BK1515","BK1161","159938","09939","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659176668","title":"每周股票复盘：福瑞达（600223）控股股东拟转让5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2659176668","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659176668?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:00","pubTimestamp":1786820443,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，福瑞达报收于5.67元，较上周的5.54元上涨2.35%。本次权益变动后，商业集团及其一致行动人持股比例由54.28%降至49.28%，山东国投将持有公司5%股份。本次变动不会导致公司控股股东及实际控制人发生变化。山东省国资委已批复同意此次转让。鲁商福瑞达医药股份有限公司拟与山东省商业集团财务有限公司签订《金融服务协议》，由财务公司为其提供存款、综合授信、结算及其他金融服务，协议有效期至2028年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0273","BK0188","600223","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659814140","title":"福瑞达（600223）披露与山东省商业集团财务有限公司签订《金融服务协议》暨关联交易公告，8月14日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659814140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659814140?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:32","pubTimestamp":1786717938,"startTime":"0","endTime":"0","summary":"近日，鲁商福瑞达医药股份有限公司发布关于与山东省商业集团财务有限公司签订《金融服务协议》暨关联交易的公告。公告显示，公司拟与山东省商业集团财务有限公司签订《金融服务协议》，由财务公司为其提供存款、综合授信、结算及其他金融服务，协议有效期至2028年12月31日。财务公司为公司第一大股东山东省商业集团有限公司的独资公司，本次交易构成关联交易，已获董事会审议通过，尚需提交股东会批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400040669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0229","BK0273","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659161746","title":"股市必读：福瑞达（600223）8月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2659161746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659161746?lang=zh_cn&edition=full","pubTime":"2026-08-14 02:38","pubTimestamp":1786646292,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，福瑞达报收于5.69元，上涨0.18%，换手率0.89%，成交量9.08万手，成交额5152.42万元。董秘最新回复投资者： 贵司股价连续5年下跌，没回回购、没有增持，请问管理层为何没有实质性的稳定股价举措？请响应国家和市场号召，尽快回购。交易信息汇总资金流向8月13日主力资金净流入41.58万元，占总成交额0.81%；游资资金净流入308.84万元，占总成交额5.99%；散户资金净流出350.41万元，占总成交额6.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0273","BK0229","BK0188","600223"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658527989","title":"福瑞达：近三年累计分红超2.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658527989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658527989?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:18","pubTimestamp":1786349889,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞达08月10日在投资者关系平台上答复投资者关心的问题。近年公司在持续推出优质新产品赢得消费者认可的同时，持续推动分红等回报投资者行为，近三年累计分红超2.7亿元。后期将结合市场情况与公司运营实际，多重举措回报股东与客户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000019191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0229","BK0188","BK0273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657402612","title":"福瑞达：通过股权合作推进业务合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2657402612","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657402612?lang=zh_cn&edition=full","pubTime":"2026-08-07 18:27","pubTimestamp":1786098435,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞达08月07日在投资者关系平台上答复投资者关心的问题。公司控股股东以协议转让方式引进山东国投作为福瑞达的战略投资者，是省属国企之间产业融合的一项重要举措。以期通过股权合作推进业务合作，包括渠道推广、新品共创等，实现提升经营效益的核心目标。山东国投将向公司提名一名非独立董事候选人，旨在充分发挥战略投资者产业协同价值，不会增加管理成本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700033696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600223","BK0273","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657606651","title":"股市必读：福瑞达新发布《鲁商福瑞达医药股份有限公司简式权益变动报告书（山东省国有资产投资控股有限公司）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657606651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657606651?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:05","pubTimestamp":1786039521,"startTime":"0","endTime":"0","summary":"本次权益变动后，山东国投持股比例为5.00%，成为持股5%以上股东，福瑞达控股股东及实际控制人未发生变更。鲁商福瑞达医药股份有限公司简式权益变动报告书山东省商业集团有限公司拟通过协议转让方式将其持有的福瑞达50,828,500股股份转让给山东省国有资产投资控股有限公司，转让价格为5.384元/股，总价273,660,644.00元。本次转让尚需山东省国资委审批及上交所合规性确认。本次权益变动不会导致公司控股股东及实际控制人发生变化，不触及要约收购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0229","600223","BK0273","BK1515","159938","BK1161","09939","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657363783","title":"福瑞达(600223.SH)控股股东拟向山东国投转让5%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2657363783","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657363783?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:39","pubTimestamp":1786023589,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福瑞达 发布公告，公司的控股股东山东省商业集团有限公司与山东省国有资产投资控股有限公司于2026年8月6日签署了《股份转让协议》。本次权益变动后，控股股东商业集团及其一致行动人的持股数量将减少5082.85万股，持股比例从54.28%降至49.28%;山东国投将持有公司5082.85万股股份，持股比例将增加至5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0273","BK0188","BK0229","600223"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657895586","title":"福瑞达：近三年累计分红超2.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657895586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657895586?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:00","pubTimestamp":1786006838,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞达(600223)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：建议贵司尽快将所有者权益中的20亿未分配利润进行分配福瑞达回复：尊敬的投资者，您好，感谢您对公司的建议！公司分红遵从经营逻辑与产业发展规律，在保障公司稳健前提下努力回报投资者，近三年累计分红超2.7亿元。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600027780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0273","BK0188","600223","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654074023","title":"福瑞达：国资股东对管理层实行综合绩效考核体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2654074023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654074023?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:12","pubTimestamp":1785226332,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞达(600223)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司股价连续几年下跌，市值大幅缩水。请问国资股东对管理层是否有市值方面的考核？福瑞达回复：尊敬的投资者，您好，感谢您对公司的关注！国资股东对管理层实行综合绩效考核体系，涵盖经营业绩、高质量发展、国资保值增值等多维度指标，重点引导管理层聚焦主业长期稳健发展。再次感谢您对公司的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800024427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600223","BK0273","BK0188","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654107402","title":"福瑞达：以夯实主业基本面为核心开展市值管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2654107402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654107402?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:12","pubTimestamp":1785226330,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞达(600223)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请介绍下贵司在市值管理方面的举措，以及效果如何，有什么改进方案福瑞达回复：尊敬的投资者，您好，感谢您对公司的关注！公司始终以夯实主业基本面为核心开展市值管理，持续规范信息披露、常态化开展投资者沟通、完善公司治理，维护公司资本市场稳定。近期公司通过“我是股东”交流会，与股东代表及机构面对面交流，会议内容详见公司2026年7月21日发布的《鲁商福瑞达医药股份有限公司投资者关系活动记录表》。再次感谢您对公司的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800024423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600223","BK0229","BK0273"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654239057","title":"每周股票复盘：福瑞达（600223）聚焦医美器械与重组胶原蛋白布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2654239057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654239057?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:59","pubTimestamp":1785005947,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，福瑞达报收于5.22元，较上周的5.5元下跌5.09%。本周，福瑞达7月20日盘中最高价报5.6元。团队兼具消费品销售与未来医美器械上市前的市场教育、医疗平台对接职能。医学美容方面，公司约5年前开始布局，现有多款Ⅱ类医疗器械获证或进入商业化阶段，Ⅲ类透明质酸水光产品、重组胶原蛋白产品正推进中。重组胶原蛋白与王浆酸新产品毛利率较高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600223","BK0229","BK0273"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788568041090,"stockEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.007},{"period":"6month","weight":-0.1916},{"period":"1year","weight":-0.2835},{"period":"ytd","weight":-0.2202}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"鲁商福瑞达医药股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"41764人(较上一季度减少6.48%)","perCapita":"24340股","listingDate":"2000-01-13","address":"山东省淄博市博山区博山经济开发区","registeredCapital":"101656万元","survey":" 鲁商福瑞达医药股份有限公司的主营业务是化妆品、医药、原料及添加剂的研发、生产与销售以及物业服务业务。公司的主要产品是化妆品、药品、原料及衍生产品、添加剂、物业服务。","listedPrice":6.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福瑞达(600223)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福瑞达(600223)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福瑞达,600223,福瑞达股票,福瑞达股票老虎,福瑞达股票老虎国际,福瑞达行情,福瑞达股票行情,福瑞达股价,福瑞达股市,福瑞达股票价格,福瑞达股票交易,福瑞达股票购买,福瑞达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福瑞达(600223)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福瑞达(600223)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}